Your browser doesn't support javascript.
loading
1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice.
Li, Yan; Wang, Chunting; Li, Dandan; Deng, Pengchi; Shao, Xiaoni; Hu, Jing; Liu, Chunqi; Jie, Hui; Lin, Yiyun; Li, Zhuoling; Qian, Xinying; Zhang, Huaqin; Zhao, Yinglan.
Afiliação
  • Li Y; Pharmacodynamics Pharmacokinetics Early Safety Evaluation Model Animals, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, P.R. China.
  • Wang C; Pharmacodynamics Pharmacokinetics Early Safety Evaluation Model Animals, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, P.R. China.
  • Li D; Pharmacodynamics Pharmacokinetics Early Safety Evaluation Model Animals, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, P.R. China.
  • Deng P; Analytical and Testing Center, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
  • Shao X; Pharmacodynamics Pharmacokinetics Early Safety Evaluation Model Animals, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, P.R. China.
  • Hu J; Pharmacodynamics Pharmacokinetics Early Safety Evaluation Model Animals, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, P.R. China.
  • Liu C; Pharmacodynamics Pharmacokinetics Early Safety Evaluation Model Animals, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, P.R. China.
  • Jie H; Pharmacodynamics Pharmacokinetics Early Safety Evaluation Model Animals, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, P.R. China.
  • Lin Y; Pharmacodynamics Pharmacokinetics Early Safety Evaluation Model Animals, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, P.R. China.
  • Li Z; Pharmacodynamics Pharmacokinetics Early Safety Evaluation Model Animals, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, P.R. China.
  • Qian X; Pharmacodynamics Pharmacokinetics Early Safety Evaluation Model Animals, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, P.R. China.
  • Zhang H; Pharmacodynamics Pharmacokinetics Early Safety Evaluation Model Animals, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, P.R. China.
  • Zhao Y; Pharmacodynamics Pharmacokinetics Early Safety Evaluation Model Animals, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, P.R. China.
Oncol Rep ; 38(5): 3044-3054, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28901465
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Metabolômica / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Oncol Rep Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de publicação: Grécia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Metabolômica / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Oncol Rep Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de publicação: Grécia